Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-18
2011-01-18
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S312000, C514S314000, C544S151000, C546S153000
Reexamination Certificate
active
07872004
ABSTRACT:
The present invention relates to a compound represented by the following formula [I]wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof, and a pharmaceutical composition, an anti-HIV agent and an HIV integrase inhibitor containing such compound. The compound of the present invention has an HIV integrase inhibitory activity, and is useful as an anti-HIV agent, or as an agent for the prophylaxis or treatment of AIDS. In addition, by the combined use with other anti-HIV agents such as a protease inhibitor, a reverse transcriptase inhibitor and the like, it can be a more effective anti-HIV agent. Because it shows integrase-specific high inhibitory activity, the compound can be a pharmaceutical agent safe on human body, which causes only a fewer side effects.
REFERENCES:
patent: 7482454 (2009-01-01), Ledoussal et al.
patent: 2005/0239819 (2005-10-01), Satoh et al.
patent: 2006/0019906 (2006-01-01), Satoh et al.
patent: 2006/0084665 (2006-04-01), Satoh et al.
patent: 2637204 (2007-08-01), None
patent: WO 99/14214 (1999-03-01), None
patent: WO 2004/046115 (2004-06-01), None
patent: WO 2005/087759 (2005-09-01), None
patent: WO 2005/113509 (2005-12-01), None
patent: WO 2006/033422 (2006-03-01), None
patent: WO 2007/090579 (2007-08-01), None
Morissette et al. Advanced Drug Delivery Reviews 2004, 56, 275-300.
Vippagunta, Sudha R. “Crystalline Solids.” Advanced Drug Delivery Reviews 48(2001): 3-26.
Written Opinion of the International Search Authority for PCT/JP2007/062579 dated Feb. 3, 2009.
De Clercq, Erik, “New Developments in Anti-HIV Chemotherapy,” Biochimica at Biophysica Acta 1587 (2002) 258-275.
Vincent, K.A., et al., “Characterization of Human Immunodefieicny Virus Type I integrase Expressed inEschericia coliand Analysis of Variants with Amino-Terminal Mutations,” J. Virol. (1993) 67:425-437.
Aramaki Hisateru
Inoue Masafumi
Kawakami Hiroshi
Matsuzaki Yuji
Nakamura Hiroshi
Finnegan Henderson Farabow Garrett & Dunner LLP
Japan Tobacco Inc.
Saeed Kamal A
Shterengarts Samantha L
LandOfFree
6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2672705